Pharmaceutical industry is a hotspot in the global economy, and as a branch of the pharmaceutical industry, the traditional Chinese medicine industry has a broader space for development
David Gu believes that the traditional Chinese medicine industry has a very broad prospect for development. As we all know, the pharmaceutical industry is the world's recognized international industry, in the latest international standard division of 28 kinds of industry, pharmaceuticals is the international exchange of the largest volume of 15 kinds of products, but also the world's fastest-growing exports of 5 kinds of products. It is expected that in the next 10 years, the global pharmaceutical sales will grow about 7% per year, and by next year, the pharmaceutical market sales will reach 400 billion-406 billion U.S. dollars, and in 2010, it will reach 680 billion-720 billion U.S. dollars. At the same time, the international botanical medicine market has also shown a rapid growth momentum, in the existing annual sales of 30 billion U.S. dollars on the basis of the rapid growth rate of an average of 10% annual growth rate. Another international organization predicts that in the next period of time, the international botanical medicine will grow rapidly to 100 billion U.S. dollars, reaching 1/6-1/4 of the total sales of the international pharmaceutical market.
With the rise of the global "back to nature" wave and a deeper understanding of the side-effects of chemicals, the international market for traditional Chinese medicine has become more and more popular. In some developed countries, traditional Chinese medicine is in vogue, which creates a broad space for traditional Chinese medicine to enter the international market, at the same time, due to the constraints of the level of productivity, China's per capita use of drugs at a low level of only 1/40 of the United States, the space for drug consumption is huge.
Chinese medicine industry is China's pharmaceutical industry in the unique characteristics and advantages of the field, the use of Chinese medicine in China has been five thousand years of historical accumulation, with a systematic theory of traditional Chinese medicine and a wealth of clinical experience. The development of traditional Chinese medicine by means of modern science and technology, compared with chemical drugs and biotechnology drugs, has the significant advantages of low risk, high hit rate, short cycle and low cost, and is an important means to participate in the competition in the pharmaceutical market, expand exports and solve the problem of medication for more than 1.2 billion people.
China's pharmaceutical industry, especially the proprietary Chinese medicine industry, is one of the fastest growing industries in the national economy since the reform and opening up. 1999, the total output value of the national traditional Chinese medicine industry has reached 38.456 billion yuan. At present, the Chinese medicine industry has initially formed a certain scale of industrial system, emerged a number of backbone enterprises and market leading varieties of traditional Chinese medicine, due to the modern Chinese medicine industry's huge market prospects and the attraction of high value-added, but also a strong national industrial policy guidance, the Chinese medicine industry has become a popular industry for investors to choose. Chinese medicine industry will certainly become a new economic growth point in China's national economy.
But the competition in the field of foreign natural medicines is becoming increasingly fierce. And relevant information and research results show that China's traditional Chinese medicine in the international market share is not ideal. In the traditional Chinese medicine industry ushered in the development of opportunities at the same time, we must soberly see, after China's accession to the WTO, more serious challenges, more intense competition will follow, foreign enterprises will beach China's market, the formation of a certain degree of threat to Chinese enterprises.
The threat of foreign enterprises is mainly reflected in the following aspects:
1, in the international demand for botanical drugs is growing rapidly at the same time, the market competition for Chinese medicine products is becoming increasingly fierce, China's traditional Chinese medicine accounted for the share of the international market and the benefits of the decline in 1996-1998 for three consecutive years of slippage in 1999, a slight rebound, but market share less than 5%, while Japan and South Korea accounted for 25%. It is worth noting that certain developed countries in the world, such as Germany, France, Japan, they are in the absence of traditional experience and theory, relying on modern scientific and technological theories to achieve a successful industrialization of the road, and a big push into our market.
2, foreign enterprises competing for low-priced acquisition of Chinese herbal resources in China, the situation is getting more and more intense, the sustainable use of Chinese medicine resources is increasingly prominent. At the same time, foreign enterprises with their capital, technology, product advantages, set a high threshold of technical barriers, green trade barriers, to the Chinese medicine products into the international market to set up barriers.
3, the rapid development of the field of biotechnology and China's accession to the WTO challenges, etc., all of which pose an all-round threat to China's traditional Chinese medicine industry. However, opportunities and challenges coexist, in a positive sense, opportunities to bring external conditions conducive to the development, while the challenge is to stimulate the development of the internal merit.
China's traditional Chinese medicine industrialization development has been equipped with the timing, location, people and conditions, ready to go, the traditional Chinese medicine industry is nurturing an upcoming industrial revolution
When it comes to the current situation of China's traditional Chinese medicine industry, Gu Dawei said the reform and opening up for 20 years, China's traditional Chinese medicine industry has made great strides in the formation of a number of strengths and needs, the implementation of high-tech reform of the backbone of the traditional Chinese medicine industry. There have been a number of industrialized scientific and technological achievements and advanced and applicable high-tech; through the implementation of the "modernization of traditional Chinese medicine industry action plan", "Ninth Five-Year Plan" Science and Technology Research Program, the State Key Basic Research Program for the industrialization of high-tech traditional Chinese medicine to provide a number of applicable results, and the initial formation of the Chinese medicine industry to provide a number of high-tech industrialization. It has provided a number of applicable achievements for the industrialization of high technology in Chinese medicine, and has initially formed the scientific and technological support conditions for the industrialization of Chinese medicine, and possessed a good policy and financing and investment environment. In short, the development of the industrialization of Chinese medicine has been equipped with the timing, geographical advantage, and human conditions, it is not polite to say, China's traditional Chinese medicine industry is sprouting a huge energy waiting to happen, breeding an upcoming industrial revolution.
We can not deny that China's traditional Chinese medicine industry is weak, relatively backward, there are still "a small, two more, three low" (small-scale enterprises, the number of enterprises, duplication of products, low technological content of enterprises, low management level, low production capacity) phenomena and problems that need to be solved, but the main problems are Low high-tech content in industrial processization. At present, there are several key issues that need to be resolved urgently. First, the advanced and applicable preparation process, high-tech and equipment, the urgent need to promote the application. The development trend of today's technological revolution in the pharmaceutical industry is rapidly developing in the direction of manufacturing process automation and system integration, thus greatly improving the intrinsic quality of the product and the stability of quality. However, as a high degree of product quality needs to ensure the quality of the Chinese medicine industry, the production process technology and its equipment is seriously lagging behind, with a 20-year gap with foreign countries, especially the extraction of traditional Chinese medicine, refining process of scientific, advanced, rigorous from the international advanced level there is still a large gap between the process conditions of the objectivity of the degree of control is not high, the lack of manufacturing technology and equipment integration, there are still quite a number of modernization of Chinese medicine There are still a number of key **** technology in the process of development needs to be resolved urgently. Therefore, we should actively rely on the combination of government, industry, academia, research, and gold, research or learn from other fields of advanced technology, the implementation of the pharmaceutical process of Chinese medicine unit manufacturing technology and equipment for the intelligent combination of applications, and its key process parameters of the on-line detection of continuous collection and programmed, automated control. This is the first key problem to be solved for the Chinese medicine industry to move towards high-tech industrialization. If the key aspects of the above process can be controlled and optimized, and the development of high-quality control of complete sets of devices and technology platforms, according to the other day 1/3 of the traditional Chinese medicine enterprises need to be transformed, this alone will be a huge market. Second, China can be intensive, standardized production of high-tech products market share needs to be improved, can participate in international competition, large-scale modern enterprise groups need to develop and cultivate. Thirdly, the quality standard and quality control system that meets the characteristics of traditional Chinese medicine and is recognized by the international community urgently needs to be established, and the innovation system for the industrialization of traditional Chinese medicine urgently needs to be established and improved. If these key issues can be resolved, the market share of the traditional Chinese medicine industry will be greatly increased.
In support of the modernization of Chinese medicine industry, the State Planning Commission has a clear development idea, but also taken a number of initiatives to support the development of Chinese medicine
Gu Dawei said, the Commission in support of the modernization of China's traditional Chinese medicine industry in the overall development of the idea is to: to the therapeutic advantages of outstanding, high market demand for modern Chinese medicine high-tech products as a leader, to the strong and large-scale enterprises as the main body, the organization of production, learning, research and innovation system, and the development of the Chinese medicine industry. As the main body, organizing a team combining production, learning, research and finance, relying on the support of advanced applicable technology, under the guidance of the government's support, through the implementation of high-tech industrialization demonstration projects for key links in the whole process of the traditional Chinese medicine industry, comprehensively improving the high-tech content of traditional Chinese medicine products, forming large-scale multinational enterprise groups of traditional Chinese medicine, rapidly increasing the share of traditional Chinese medicine products in the domestic and international markets, so that the traditional Chinese medicine industry will be developed into an industry based on High-technology-intensive enterprises and independent intellectual property rights-based products, with strong international competitiveness, sustainable development of large-scale modern industries, and become a new growth point of China's economy.
The State Planning Commission decided to implement this strategy in the form of "special support". Through the construction of modern Chinese medicine demonstration project to enhance the overall level of China's traditional Chinese medicine industry, promote the structural adjustment of the traditional Chinese medicine industry, to open up new areas of industry, through the strengthening of the modern traditional Chinese medicine industry's basic support conditions for the realization of the development of leapfrog to provide technical support to cultivate a number of single product on the scale of the traditional Chinese medicine enterprises, such as in the field of anticancer has a certain impact on the Harbin Pharmaceutical Cihang and other pharmaceutical companies. In particular, we will accelerate the industrialization of high-tech traditional Chinese medicine, demonstrate the application of advanced extraction, separation, preparation and production process system control technology, enable a group of representative backbone enterprises of traditional Chinese medicine to achieve comprehensive technological upgrading in production process and equipment level, establish demonstration projects and industrialization bases for the radiation of technology to the whole industry, and promote the implementation of the strategy of "big enterprises, big varieties and big market". Promote the implementation of the strategy of "big enterprise, big variety, big market". Accelerate the industrialization of modern products with independent intellectual property rights, high technology content, high value-added products, so that China's traditional Chinese medicine in China's accession to the WTO with strong competitiveness.
The implementation of special support for the industrialization of modern Chinese medicine will make the scale of China's traditional Chinese medicine industry (mainly referring to traditional Chinese medicine planting agriculture and traditional Chinese medicine industry) reach an annual output value of 80-100 billion yuan by 2005, with an average annual growth rate of more than 16%; the annual export of traditional Chinese medicine products will reach 10-12 billion yuan, accounting for more than 10 percent of the traditional Chinese medicine The annual export value of Chinese medicine products reaches 10-12 billion yuan, accounting for more than 10% of the industrial output value of Chinese medicine, with an average annual increase of 20%; the annual profit and tax reaches 15 billion yuan, with an average annual increase of 10%, among which the profit reaches 5 billion yuan, with an average annual increase of 10%; the technical level of the industry is significantly improved; the proportion of high and new-technology products accounts for 30% of the total value of the Chinese medicine industry, and the contribution of the technological progress to the growth rate of the Chinese medicine industry is more than 45%; the structure of the industry is further optimized, and the key enterprises of the Chinese medicine industry will be 50, the output value of 70% of the industry, 200 key products of large enterprise groups, of which 30 annual output value of more than 500 million yuan, more than 100 million yuan or more than 100, accounting for about 30% of the output value of traditional Chinese medicine products, so that the traditional Chinese medicine industry has become a veritable pillar industry.